BTREX PLUS, Dietary Supplement 100 Caplets
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0484-2021.
cGMP Deviation: Presence of damaged tablets
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0484-2021.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Lopez Gonzalez Santana Corporation or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0484-2021.
Lopez Gonzalez Santana Corporation
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Lopez Gonzalez Santana Corporation Recall FAQ
Lopez Gonzalez Santana Corporation is the subject of a supplements safety report: BTREX PLUS, Dietary Supplement 100 Caplets. The notice was published on April 20, 2021 by the U.S. Food and Drug Administration (FDA). Approximately 311 units are potentially affected.